Financial Wire

Research Alert: Alcoa's Q1 Misses Consensus, Pricing Strength Offsets Volume Disruptions

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

AA reported Q1 2026 adj. EPS of $1.40 vs. $2.15 Y/Y, missing consensus by $0.15, while revenue of $3.19B declined 5.2% Y/Y (-7% Q/Q) and missed estimates by 2.3%. Adj. EBITDA increased 13% sequentially to $595M despite volume headwinds from the Middle East conflict and Cyclone Narelle, as realized aluminum prices improved 12% Q/Q to $4,209 per metric ton. We view results as constructive despite external disruptions, with AA demonstrating strong operational leverage to aluminum pricing and successful San Ciprian smelter restart completion in April. Management maintained full-year 2026 production guidance of 9.7M-9.9M metric tons for alumina and 2.4M-2.6M metric tons for aluminum. For Q2, we expect aluminum segment EBITDA to improve ~$55M from inventory repositioning and San Ciprian benefits, though partially offset by ~$15M alumina headwinds and $35M sequential increase in Section 232 tariff costs. AA's strong $1.4B cash position and $219M debt reduction show disciplined allocation.

Related Articles

Asia

American Uranium Launches Nearly AU$3 Million Entitlement Offer

American Uranium (ASX:AMU) launched a pro rata non-renounceable rights issue to raise around AU$2.6 million before costs, offering eligible shareholders in Australia, New Zealand, and Canada one new share for every six held at AU$0.12 per share, according to a Friday filing with the Australian bourse.The participants will also receive one free attaching option for every two new shares subscribed, exercisable at AU$0.16 and expiring on June 30, 2029, although these options will not be listed on the Australian Securities Exchange, per the filing.New shares will rank equally with existing shares, while shareholders may take up all, part, or none of their entitlement, with any shortfall potentially allocated to exempt investors at directors' discretion within three months of closing, the filing said.The proceeds will be used to fund permitted infill and expansion drilling, as well as hydrogeological and metallurgical programs at Lo Herma in Wyoming, US, in preparation for the planned third quarter scoping study, the filing added.

$ASX:AMU
Asia

AMP Accelerated Momentum Across Core Business Units in Q1, Jefferies Says

AMP (ASX:AMP) reported "encouraging" first-quarter results as momentum accelerated across its core business units, and AMP Bank recorded only a minor decrease in loan balances from the linked quarter, Jefferies said in a Thursday note.The company's North wealth management platform saw a robust AU$1.1 billion of new inflows, representing the fourth consecutive quarter of net inflows topping the AU$1 billion mark. The Superannuation and Investments division posted "a continued and meaningful improvement" as net cash outflows contracted to AU$80 million, Jefferies said.In its international businesses, the outlook for AMP's China Life ventures is buoyed by structural demographic tailwinds, while AMP New Zealand performed well with positive new cash inflows of AU$41 million in the quarter, the equity research firm said.The company's AU$150 million on-market buyback is now included in forecasts, which Jefferies estimates to be around 4% accretive. Including overall forecasting adjustments, the firm's EPS forecasts for AMP increase 6% for 2026 and 8% for 2027.Jefferies maintained a buy rating on AMP and raised its price target on the company's shares to AU$1.75 from AU$1.50.

$ASX:AMP
Asia

Orthocell Says First Surgical Case Using Nerve Repair Product in US Department of Defense Hospital Network Completed

Orthocell (ASX:OCC) said that a surgery at a military base hospital in Ohio within the US Department of Defense/Veterans Affairs hospital network was the first surgical case using its nerve repair product, Remplir, according to a Friday Australian bourse filing.The company said that this represented an important step in its US commercialization strategy.

$ASX:OCC
Research Alert: Alcoa's Q1 Misses Consensus, Pricing Strength Offsets Volume Disruptions | Financial Wire